Skip to Content

Alosetron Pregnancy and Breastfeeding Warnings

Alosetron is also known as: Lotronex

Alosetron Pregnancy Warnings

Animal models have failed to reveal evidence of impaired fertility and fetal harm at doses up to 40 mg/kg/day. There are no adequate and well-controlled studies in pregnancy.

US FDA pregnancy category B: Animal reproduction studies have failed to demonstrate a risk to the fetus and there are no adequate and well-controlled studies in pregnant women.

This drug should be used during pregnancy only if clearly needed.

US FDA pregnancy category: B

See references

Alosetron Breastfeeding Warnings

Caution is recommended.

Excreted into human milk: Unknown
Excreted into animal milk: Yes

Comment: The effects in the nursing infant are unknown.

See references

References for pregnancy information

  1. "Product Information. Lotronex (alosetron)." Glaxo Wellcome, Research Triangle Park, NC.

References for breastfeeding information

  1. "Product Information. Lotronex (alosetron)." Glaxo Wellcome, Research Triangle Park, NC.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Hide